Top

01-09-2018 | Pathophysiology | Review | Article

Sodium–glucose transporter as a novel therapeutic target in disease

Yamazaki Y et al. Eur J Pharmacol 2018; 822: 25–31. doi: 10.1016/j.ejphar.2018.01.003

Please follow the link below to view this article in full on a third-party website. Note that a subscription or payment may be required.

https://doi.org/10.1016/j.ejphar.2018.01.003

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials

Jean-Pierre Riveline uses data from real-life continuous glucose monitoring studies to illustrate how these can uncover critical information about clinical outcomes that are hard to assess in randomized controlled trials.

This video has been developed through unrestricted educational funding from Abbott Diabetes Care.

Watch the video

Medicine Matters Diabetes

Novel clinical evidence in continuous glucose monitoring

How real-world studies complement randomized controlled trials